New transplant prep shows promise for older, sicker blood cancer patients
NCT ID NCT03159702
Summary
This study tested a new, potentially safer drug combination to prepare patients for a half-matched bone marrow transplant. It involved 43 adults with blood cancers like multiple myeloma who could not tolerate standard high-dose treatments. The goal was to see if this gentler preparation method could control the cancer while reducing serious side effects and improving survival one year after transplant.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Froedtert Hospital & the Medical College of Wisconsin
Milwaukee, Wisconsin, 53226, United States
Conditions
Explore the condition pages connected to this study.